Biotech Leaders Ponder Tariff Ramifications

Several biotech execs said they don’t expect much impact from the Trump administration’s threatened tariffs but are reviewing business practices to prepare.

Potential US tariffs' impact on pharmaceuticals has biotechs considering their options (Shutterstock)

More from Financing

More from Supply Chain